Stemina Biomarker Discovery, Inc.

Stemina Biomarker Discovery, Inc. is a biotechnology startup founded in 2006 and headquartered in the United States. The company's slogan, "Pioneer of human in vitro systems for toxicology and compound safety screening to improve human health," reflects its focus on improving drug safety and human health through the discovery, development, and commercialization of molecular biomarkers. Stemina's unique approach involves the utilization of human embryonic stem (hES) cells and metabolomics to create cell-based assays that analyze the small molecules secreted by hES cells in response to drugs, injury, or disease using mass spectrometry. In January 2017, Stemina secured a $3.10M Venture Round investment from Wisconsin Investment Partners, BrightStar Wisconsin Foundation, and NeuroNetworks Fund. The company's state-of-the-art facilities for hES cell culture and mass spectrometry, located in the UW Research Park in Madison Wisconsin, showcase its commitment to advancing innovation in the field of biotechnology.